GC Biopharma Secures Major Approval for Varicella Vaccine Launch in Guatemala GC Biopharma has received marketing authorization for its varicella vaccine, BARYCELA, in Guatemala, marking a crucial step in expanding access to vaccinations in Latin America.

GC Biopharma Secures Major Approval for Varicella Vaccine Launch in Guatemala #GC_Biopharma #Guatemala #vaccines #Guatemala_City #BARYCELA

GC Biopharma Initiates Phase 3 Clinical Trial for BARYCELA Vaccine in Thailand GC Biopharma has submitted an IND for a Phase 3 trial of BARYCELA, a varicella vaccine, aiming for approval in Southeast Asia by 2027.

GC Biopharma Initiates Phase 3 Clinical Trial for BARYCELA Vaccine in Thailand #South_Korea #GC_Biopharma #Yongin #Phase_3_Trial #BARYCELA

GC Biopharma's BARYCELA Vaccine Awarded Marketing Authorization in Vietnam GC Biopharma's varicella vaccine BARYCELA has secured marketing authorization in Vietnam, a key step in its Southeast Asian expansion strategy.

GC Biopharma's BARYCELA Vaccine Awarded Marketing Authorization in Vietnam #Vietnam #GC_Biopharma #Yongin #BARYCELA #Varicella_Vaccine